The role of microbial populations in the cycling of iron and manganese from marine aggregates

Marine aggregates play an important role in the cycling of carbon, nutrients and tracemetals. Within aggregates the oxygen depleted by aerobic microbial respiration maynot be replaced rapidly, generating anoxic or suboxic microzones. Reducedcompounds that are unstable in the oxygenated water column have been previouslyfound associated with marine snow. Therefore, in the experiments described in thisthesis, artificial aggregates were made in the laboratory from senescent phytoplanktonmaterial and incubated to investigate the role of the associated microbial populationsto the biogeochemical redox cycling of iron and manganese and to the degradation oforganic matter.The release of dissolved iron from artificial aggregates which did not contain anymeasurable (~10 ?m) anoxic microzones, was demonstrated under dark conditions.The rate of release was controlled by the amount of reducible Fe(III) available, andappears to be limited by the competing oxidation of Fe(II). Moreover highly significantreleases in reduced Mn were detected from aggregates incubated under a constantvelocity shear, although the same aggregates did not affect the dissolution of iron. Apossible reason is likely associated with the higher stability of Mn(II), compared toFe(II) in aerobic environments.Molecular (16S rRNA gene) analyses showed the bacterial communityassociated with artificial aggregates to be similar to that found in natural aggregatesand dominated by (predominantly uncultured) ?- and ?-Proteobacteria, Bacteroidetes,Planctomycetes and Cyanobacteria. It was possible to culture NO3--, Fe(III)- andMn(IV)-reducing bacteria from the artificial aggregates, and marine particles incubatedwith Fe(III) under anaerobic conditions contained a range of ?- and ?-Proteobacteriaknown to respire Fe(III) and in most cases Mn(IV). Moreover several microorganismsbelonging to ?-Proteobacteria were isolated from marine aggregates and strainsaffiliated to the genera Amphritea, Marinobacterium and Marinobacter, weredemonstrated to grow through the reduction of Fe(III), with Marinobacter also capableof respiring Mn(IV). Whilst the precise mechanism of reduction is not clear, it is evidentthat marine aggregates can be a source of Fe(II) and dissolved Mn, in coastal watersand most probably other natural water systems.Fatty acid analyses revealed the prevalence of saturated over unsaturated fattyacids indicating that aggregates were already partially degraded when incubationstarted. Nonetheless, the lipids in the artificial aggregates were rapidly degradedfurther as indicated by a depletion in short chain (<20) saturated andmonounsaturated fatty acids. In contrast, the concentrations of linear and branched,saturated long chain (>20) fatty acids fluctuated, suggesting that some of these lipidscould have been produced in situ by marine microorganisms rather than deriving fromIIhigher plant debris. In addition, a bacterial branched monounsaturated fatty acid (11-methyl-octadecenoic acid), which has not previously been found in marine particleswas present in artificial aggregates. Roseobacter litoralis found among the aggregateattachedbacteria contains 11-methyl-octadecenoic acid, and other bacteria present inartificial aggregates have the potential to produce long-chain saturated andpolyunsaturated fatty acids. Thus, the fatty acid assemblage appears to reflect bothorganic matter degradation, including selective preservation, but also changes in themicrobial assemblage.A range of future studies are suggested to elucidate the mechanisms for Fe(III)and Mn(IV) reduction in aggregates. These include microscale analyses of dissolvedspecies and evaluation of the presence of metal binding ligands associated withaggregates. Moreover it is important to assess the activity of the Fe(III)- and Mn(IV)-reducing bacteria present in aggregates in situ and the production of long chain fattyacids in degrading aggregates

Bacterial production of transparent exopolymer particles during static and laboratory-based cross-flow experiments

Open Access Article. This article is licensed under a Creative Commons Attribution 3.0 Unported Licence.Biofouling of seawater reverse osmosis (SWRO) membranes represents one of the leading causes of performance deterioration in the desalination industry. This work investigates the biofouling potential of microbial communities present in a reverse osmosis (RO) feed tank. As an example, water from the RO feed tank of the Penneshaw desalination plant (Kangaroo Island, South Australia) was used in a static biofilm formation experiment. Cultures of the indigenous biofilms formed during the static experiment showed that α-Proteobacteria and γ-Proteobacteria accounted for nearly 80% of the classes of bacteria present in the RO feed tank. Pseudomonas sp. was identified as the major species and isolated for testing in static and laboratory-based cross flow biofilm formation experiments. Results showed that the volume of TEPs generated by Pseudomonas sp. during the laboratory-based cross-flow experiment was 10 fold higher to that produced during the static experiment for the same time period, while both experiments were inoculated with cell concentrations of the same order of magnitude. The availability of nutrients was also shown to be a key driver in TEP production, particularly for the static experiments. This study provides insights into the phenomenon of biofouling by assessing the production of biofouling precursors from one of the main genera of biofilm-forming bacteria, namely Pseudomonas sp

Antioxidant and Photoprotection Networking in the Coastal Diatom <i>Skeletonema marinoi</i>

Little is known on the antioxidant activity modulation in microalgae, even less in diatoms. Antioxidant molecule concentrations and their modulation in microalgae has received little attention and the interconnection between light, photosynthesis, photoprotection, and antioxidant network in microalgae is still unclear. To fill this gap, we selected light as external forcing to drive physiological regulation and acclimation in the costal diatom Skeletonema marinoi. We investigated the role of light regime on the concentration of ascorbic acid, phenolic compounds and among them flavonoids and their connection with photoprotective mechanisms. We compared three high light conditions, differing in either light intensity or wave distribution, with two low light conditions, differing in photoperiod, and a prolonged darkness. The change in light distribution, from sinusoidal to square wave distribution was also investigated. Results revealed a strong link between photoprotection, mainly relied on xanthophyll cycle operation, and the antioxidant molecules and activity modulation. This study paves the way for further investigation on the antioxidant capacity of diatoms, which resulted to be strongly forced by light conditions, also in the view of their potential utilization in nutraceuticals or new functional cosmetic products

Transcriptome analyses to investigate symbiotic relationships between marine protists

International audienceRhizaria are an important component of oceanic plankton communities worldwide. A number of species harbor eukaryotic microalgal symbionts, which are horizontally acquired in the environment at each generation. Although these photosymbioses are determinant for Rhizaria ability to thrive in oceanic ecosystems, the mechanisms for symbiotic interactions are unclear. Using high-throughput sequencing technology (i.e., 454), we generated large Expressed Sequence Tag (EST) datasets from four uncultured Rhizaria, an acantharian (Amphilonche elongata), two polycystines (Collozoum sp. and Spongosphaera streptacantha), and one phaeodarian (Aulacantha scolymantha). We assessed the main genetic features of the host/symbionts consortium (i.e., the holobiont) transcriptomes and found rRNA sequences affiliated to a wide range of bacteria and protists in all samples, suggesting that diverse microbial communities are associated with the holobionts. A particular focus was then carried out to search for genes potentially involved in symbiotic processes such as the presence of c-type lectins-coding genes, which are proteins that play a role in cell recognition among eukaryotes. Unigenes coding putative c-type lectin domains (CTLD) were found in the species bearing photosynthetic symbionts (A. elongata, Collozoum sp., and S. streptacantha) but not in the non-symbiotic one (A. scolymantha). More particularly, phylogenetic analyses group CTLDs from A. elongata and Collozoum sp. on a distinct branch from S. streptacantha CTLDs, which contained carbohydrate-binding motifs typically observed in other marine photosymbiosis. Our data suggest that similarly to other well-known marine photosymbiosis involving metazoans, the interactions of glycans with c-type lectins is likely involved in modulation of the host/symbiont specific recognition in Radiolaria

Hydrogen isotopic ratios of long-chain diols reflect salinity

Long-chain diols (LCDs) are ubiquitous lipids produced by freshwater and marine algae. A combination of semi-preparative high performance liquid chromatography and gas chromatography isotope ratio monitoring mass spectrometry, allowed the measurement of δ2H of individual LCDs from cultures, which indicated a correlation with the hydrogen isotope composition of the growth water and a species-specific effect. Results from environmental samples along a salinity gradient indicated the potential of δ2H ratios of LCDs to trace the hydrogen isotopic composition of water and sea surface salinity.ISSN:0146-638

Chronic constipation diagnosis and treatment evaluation: The "CHRO.CO.DI.T.E." study

Background: According to Rome criteria, chronic constipation (CC) includes functional constipation (FC) and irritable bowel syndrome with constipation (IBS-C). Some patients do not meet these criteria (No Rome Constipation, NRC). The aim of the study was is to evaluate the various clinical presentation and management of FC, IBS-C and NRC in Italy. Methods: During a 2-month period, 52 Italian gastroenterologists recorded clinical data of FC, IBS-C and NRC patients, using Bristol scale, PAC-SYM and PAC-QoL questionnaires. In addition, gastroenterologists were also asked to record whether the patients were clinically assessed for CC for the first time or were in follow up. Diagnostic tests and prescribed therapies were also recorded. Results: Eight hundred seventy-eight consecutive CC patients (706 F) were enrolled (FC 62.5%, IBS-C 31.3%, NRC 6.2%). PAC-SYM and PAC-QoL scores were higher in IBS-C than in FC and NRC. 49.5% were at their first gastroenterological evaluation for CC. In 48.5% CC duration was longer than 10 years. A specialist consultation was requested in 31.6%, more frequently in IBS-C than in NRC. Digital rectal examination was performed in only 56.4%. Diagnostic tests were prescribed to 80.0%. Faecal calprotectin, thyroid tests, celiac serology, breath tests were more frequently suggested in IBS-C and anorectal manometry in FC. More than 90% had at least one treatment suggested on chronic constipation, most frequently dietary changes, macrogol and fibers. Antispasmodics and psychotherapy were more frequently prescribed in IBS-C, prucalopride and pelvic floor rehabilitation in FC. Conclusions: Patients with IBS-C reported more severe symptoms and worse quality of life than FC and NRC. Digital rectal examination was often not performed but at least one diagnostic test was prescribed to most patients. Colonoscopy and blood tests were the "first line" diagnostic tools. Macrogol was the most prescribed laxative, and prucalopride and pelvic floor rehabilitation represented a "second line" approach. Diagnostic tests and prescribed therapies increased by increasing CC severity

REDISCOVER International Guidelines on the Perioperative Care of Surgical Patients With Borderline-resectable and Locally Advanced Pancreatic Cancer

OBJECTIVE: The REDISCOVER consensus conference aimed at developing and validate guidelines on the perioperative care of patients with borderline resectable (BR-) and locally advanced (LA) pancreatic ductal adenocarcinoma (PDAC).SUMMARY BACKGROUND DATA: Coupled with improvements in chemotherapy and radiation, the contemporary approach to pancreatic surgery supports resection of BR-PDAC and, to a lesser extent, LA-PDAC. Guidelines outlining the selection and perioperative care for these patients are lacking.METHODS: The Scottish Intercollegiate Guidelines Network (SIGN) methodology was used to develop the REDISCOVER guidelines and create recommendations. The Delphi approach was used to reach consensus (agreement ≥80%) among experts. Recommendations were approved after a debate and vote among international experts in pancreatic surgery and pancreatic cancer management. A Validation Committee used the AGREE II-GRS tool to assess the methodological quality of the guidelines. Moreover, an independent multidisciplinary advisory group revised the statements to ensure adherence to non-surgical guidelines.RESULTS: Overall, 34 recommendations were created targeting centralization, training, staging, patient selection for surgery, possibility of surgery in uncommon scenarios, timing of surgery, avoidance of vascular reconstruction, details of vascular resection/reconstruction, arterial divestment, frozen section histology of perivascular tissue, extent of lymphadenectomy, anticoagulation prophylaxis and role of minimally invasive surgery. The level of evidence was however low for 29 of 34 clinical questions. Participants agreed that the most conducive mean to promptly advance our understanding in this field is to establish an international registry addressing this patient population ( https://rediscover.unipi.it/ ).CONCLUSIONS: The REDISCOVER guidelines provide clinical recommendations pertaining to pancreatectomy with vascular resection for patients with BR- and LA-PDAC, and serve as the basis of a new international registry for this patient population.</p

REDISCOVER International Guidelines on the Perioperative Care of Surgical Patients With Borderline-resectable and Locally Advanced Pancreatic Cancer

OBJECTIVE: The REDISCOVER consensus conference aimed at developing and validate guidelines on the perioperative care of patients with borderline resectable (BR-) and locally advanced (LA) pancreatic ductal adenocarcinoma (PDAC).SUMMARY BACKGROUND DATA: Coupled with improvements in chemotherapy and radiation, the contemporary approach to pancreatic surgery supports resection of BR-PDAC and, to a lesser extent, LA-PDAC. Guidelines outlining the selection and perioperative care for these patients are lacking.METHODS: The Scottish Intercollegiate Guidelines Network (SIGN) methodology was used to develop the REDISCOVER guidelines and create recommendations. The Delphi approach was used to reach consensus (agreement ≥80%) among experts. Recommendations were approved after a debate and vote among international experts in pancreatic surgery and pancreatic cancer management. A Validation Committee used the AGREE II-GRS tool to assess the methodological quality of the guidelines. Moreover, an independent multidisciplinary advisory group revised the statements to ensure adherence to non-surgical guidelines.RESULTS: Overall, 34 recommendations were created targeting centralization, training, staging, patient selection for surgery, possibility of surgery in uncommon scenarios, timing of surgery, avoidance of vascular reconstruction, details of vascular resection/reconstruction, arterial divestment, frozen section histology of perivascular tissue, extent of lymphadenectomy, anticoagulation prophylaxis and role of minimally invasive surgery. The level of evidence was however low for 29 of 34 clinical questions. Participants agreed that the most conducive mean to promptly advance our understanding in this field is to establish an international registry addressing this patient population ( https://rediscover.unipi.it/ ).CONCLUSIONS: The REDISCOVER guidelines provide clinical recommendations pertaining to pancreatectomy with vascular resection for patients with BR- and LA-PDAC, and serve as the basis of a new international registry for this patient population.</p

Clinical Features, Cardiovascular Risk Profile, and Therapeutic Trajectories of Patients with Type 2 Diabetes Candidate for Oral Semaglutide Therapy in the Italian Specialist Care

Introduction: This study aimed to address therapeutic inertia in the management of type 2 diabetes (T2D) by investigating the potential of early treatment with oral semaglutide. Methods: A cross-sectional survey was conducted between October 2021 and April 2022 among specialists treating individuals with T2D. A scientific committee designed a data collection form covering demographics, cardiovascular risk, glucose control metrics, ongoing therapies, and physician judgments on treatment appropriateness. Participants completed anonymous patient questionnaires reflecting routine clinical encounters. The preferred therapeutic regimen for each patient was also identified. Results: The analysis was conducted on 4449 patients initiating oral semaglutide. The population had a relatively short disease duration (42%  60% of patients, and more often than sitagliptin or empagliflozin. Conclusion: The study supports the potential of early implementation of oral semaglutide as a strategy to overcome therapeutic inertia and enhance T2D management

<i>Amphidinium</i> spp. as a Source of Antimicrobial, Antifungal, and Anticancer Compounds

Dinoflagellates make up the second largest marine group of marine unicellular eukaryotes in the world ocean and comprise both heterotrophic and autotrophic species, encompassing a wide genetic and chemical diversity. They produce a plethora of secondary metabolites that can be toxic to other species and are mainly used against predators and competing species. Dinoflagellates are indeed often responsible for harmful algal bloom, where their toxic secondary metabolites can accumulate along the food chain, leading to significant damages to the ecosystem and human health. Secondary metabolites from dinoflagellates have been widely investigated for potential biomedical applications and have revealed multiple antimicrobial, antifungal, and anticancer properties. Species from the genus Amphidinium seem to be particularly interesting for the production of medically relevant compounds. The present review aims at summarising current knowledge on the diversity and the pharmaceutical properties of secondary metabolites from the genus Amphidinium. Specifically, Amphidinium spp. produce a range of polyketides possessing cytotoxic activities such as amphidinolides, caribenolides, amphidinins, and amphidinols. Potent antimicrobial properties against antibiotic-resistant bacterial strains have been observed for several amphidinins. Amphidinols revealed instead strong activities against infectious fungi such as Candida albicans and Aspergillus fumigatus. Finally, compounds such as amphidinolides, isocaribenolide-I, and chlorohydrin 2 revealed potent cytotoxic activities against different cancer cell lines. Overall, the wide variety of antimicrobial, antifungal, and anticancer properties of secondary metabolites from Amphidinium spp. make this genus a highly suitable candidate for future medical applications, spanning from cancer drugs to antimicrobial products that are alternatives to currently available antibiotic and antimycotic products